🇲🇽 The Mexico Active Pharmaceutical Ingredients (API) Market is projected to rise from US$4.39 billion in 2024 to US$7.42 billion by 2033, growing at a healthy CAGR of 6.02% 📈
Mexico is emerging as a key pharma manufacturing hub in Latin America, supported by innovation, investment, and favorable trade regulations.
🔗 Read full report: 👉 https://www.renub.com/mexico-active-pharmaceutical-ingredients-market-p.php
📊 #Pharmaceuticals #APIMarket #MexicoMarket #HealthcareIndustry #GenericDrugs #PharmaManufacturing #LifeSciences #RenubResearch
Mexico is emerging as a key pharma manufacturing hub in Latin America, supported by innovation, investment, and favorable trade regulations.
🔗 Read full report: 👉 https://www.renub.com/mexico-active-pharmaceutical-ingredients-market-p.php
📊 #Pharmaceuticals #APIMarket #MexicoMarket #HealthcareIndustry #GenericDrugs #PharmaManufacturing #LifeSciences #RenubResearch
🇲🇽 The Mexico Active Pharmaceutical Ingredients (API) Market is projected to rise from US$4.39 billion in 2024 to US$7.42 billion by 2033, growing at a healthy CAGR of 6.02% 📈
Mexico is emerging as a key pharma manufacturing hub in Latin America, supported by innovation, investment, and favorable trade regulations.
🔗 Read full report: 👉 https://www.renub.com/mexico-active-pharmaceutical-ingredients-market-p.php
📊 #Pharmaceuticals #APIMarket #MexicoMarket #HealthcareIndustry #GenericDrugs #PharmaManufacturing #LifeSciences #RenubResearch
0 Comments
0 Shares